IE
YARW

Israel Englander’s Yarrow Bioscience YARW Stock Holding History

Israel Englander’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-220
Closed -$33.7K – 6605
2024
Q1 		$33.7K Sell
220
-125
-36% -$13.5K ﹤0.01% 5750
2023
Q4 		$40.2K Buy
+345
New +$53.8K ﹤0.01% 5518
2023
Q2 		– Sell
-546
Closed -$84K – 6741
2023
Q1 		$84K Buy
546
+4
+0.7% +$718 ﹤0.01% 5477
2022
Q4 		$73K Buy
542
+321
+145% +$64.1K ﹤0.01% 5678
2022
Q3 		$44K Buy
221
+38
+21% +$12.2K ﹤0.01% 6230
2022
Q2 		$64K Sell
183
-210
-53% -$88.1K ﹤0.01% 6097
2022
Q1 		$230K Sell
393
-86
-18% -$51.1K ﹤0.01% 5751
2021
Q4 		$440K Sell
479
-1
-0.2% -$1.07K ﹤0.01% 5172
2021
Q3 		$601K Sell
480
-275
-36% -$533K ﹤0.01% 5185
2021
Q2 		$2.38M Buy
755
+726
+2,503% +$2.87M ﹤0.01% 3754
2021
Q1 		$178K Buy
+29
New +$210K ﹤0.01% 5529
2020
Q4 		– Sell
-12
Closed -$70 – 5629
2020
Q3 		$70 Sell
12
-369
-97% -$2.15M ﹤0.01% 4271
2020
Q2 		$2.38M Buy
+381
New +$2.58M ﹤0.01% 2398
2018
Q3 		– Sell
-59
Closed -$1.74M – 4311
2018
Q2 		$1.74M Buy
+59
New +$2.29M ﹤0.01% 2494

Other funds holding YARW

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Exome Asset Management New York $162M AUM 259.04% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM

Israel Englander's YARW Position: Q2 2024 in Review

Israel Englander sold out of Yarrow Bioscience (YARW) in Q2 2024, closing a stake of 220 shares — an estimated $33.7K sold.

Israel Englander first reported a position in YARW in Q2 2018 and held it in 14 quarters. The position peaked at $2.38M in Q2 2021. 31 funds tracked by Wall St. Rank hold YARW as of Q2 2024.

  • Israel Englander reported no remaining Yarrow Bioscience position as of Q2 2024 after selling out during the quarter.
  • Israel Englander sold 220 Yarrow Bioscience shares in Q2 2024, an estimated $33.7K.
  • Israel Englander first reported a position in Yarrow Bioscience in Q2 2018 and held it in 14 quarters.
  • Israel Englander's Yarrow Bioscience position peaked at $2.38M in Q2 2021.
  • 31 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2024.

Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.